Figure 2From: Clinical and laboratory characteristics of systemic anaplastic large cell lymphoma in Chinese patientsOverall survival by Ann Arbor stage. (A) The 5-year OS of 73 evaluable patients with S-ALCL by stage I, II, III and IV is 78%, 59%, 28% and 14%, respectively (P = 0.000). (B) The 5-year OS of 33 patients with ALK- S-ALCL by stage I/II and III/IV is 58% and 20%, respectively (P = 0.016). n = patient numbers in each group.Back to article page